Congenital erythrocytosis [PDF]
International Journal of Laboratory Hematology, 2016 SummaryIntroductionCongenital erythrocytosis is by definition present from birth. Patients frequently present in childhood or as young adults and a family history may be present. The erythrocytosis can be primary where there is a defect in the erythroid compartment of secondary where increased erythropoietin production produced due to the defect leads ...
Mary Frances Mcmullin
exaly +6 more sources
Erythrocytosis associated with IgA nephropathy [PDF]
EBioMedicine, 2022 Summary: Background: Erythrocytosis is a hematological disorder usually related to hematopoietic stem cell somatic mutations. However, unexplained erythrocytosis remains frequent.
Monteiro R +2 more
exaly +4 more sources
Erythrocytosis and CKD: A Review [PDF]
American Journal of Kidney DiseasesErythrocytosis or polycythemia is defined as an increase in red blood cell concentration above the age- and sex-specific normal levels. Unlike anemia, which is very common in patients with chronic kidney disease (CKD), erythrocytosis is less frequent but requires specific understanding by health care professionals in order to provide the best care ...
Michel Jadoul +2 more
exaly +5 more sources
The classification and diagnosis of erythrocytosis [PDF]
International Journal of Laboratory Hematology, 2008 SummaryAn absolute erythrocytosis is present when the red cell mass is raised and the haematocrit is elevated above prescribed limits. Causes of an absolute erythrocytosis can be primary where there is an intrinsic problem in the bone marrow and secondary where there an event outside the bone marrow driving erythropoiesis.
Mary Frances Mcmullin
exaly +6 more sources
A Prospective Observational Study: Are There Any Relationships Between Erythrocytosis, Renal Tubular–Glomerular Functions, and Systemic Hypertension in Adolescent Male Idiopathic Erythrocytosis Patients? [PDF]
ChildrenBackground: Childhood hypertension is an important predictor of adult cardiovascular disease. Idiopathic erythrocytosis in adolescent males is characterized by elevated hemoglobin and hematocrit levels, which may increase blood viscosity and potentially ...
Nesrin Tas +3 more
doaj +2 more sources
Vaping‐Induced Erythrocytosis Resolved With Cessation of e‐Cigarette Use [PDF]
Clinical Case ReportsVaping use is a global health concern with multiple adverse general health effects. We report a young man with vaping‐induced erythrocytosis that resolved following cessation of e‐cigarette use.
Jenyvette Hsia +4 more
doaj +2 more sources
Myomatous erythrocytosis syndrome: a critical diagnosis in women with uterine leiomyoma: a case report [PDF]
Journal of Medical Case ReportsBackground Myomatous erythrocytosis syndrome is an uncommon paraneoplastic syndrome of erythrocytosis associated with benign uterine leiomyomas. Fewer than 70 cases have been reported globally, and clinical awareness remains limited. Case presentation We
Soheila Aminimoghaddam +2 more
doaj +2 more sources
Prevalence and thrombotic risk of SGLT-2 inhibitor-associated erythrocytosis: a retrospective cohort study [PDF]
Cardiovascular DiabetologyBackground Sodium-glucose cotransporter 2 (SGLT-2) inhibitors, widely used for type 2 diabetes and cardiorenal conditions, may induce erythrocytosis, potentially increasing cardiovascular risk.
Ji Yun Lee +16 more
doaj +2 more sources
Erythrocytosis incidence and thromboembolic risk in heart failure with reduced ejection fraction treated with SGLT2 inhibitors: a nationwide register-based cohort study [PDF]
Cardiovascular DiabetologyBackground Sodium-glucose cotransporter-2 inhibitors (SGLT2i) increase haemoglobin and haematocrit levels, potentially causing secondary erythrocytosis—defined as a haemoglobin level above 16.5 g/dL in men and 16.0 g/dL in women—which is associated with ...
Abdullahi Ahmed Mohamed +15 more
doaj +2 more sources
Erythrocytosis and thromboembolic risks associated with SGLT2 inhibitors in type 2 diabetes [PDF]
Scientific ReportsThis study aimed to determine if sodium-glucose co-transporter-2 inhibitors (SGLT2i) use in diabetic patients leads to erythrocytosis and increases the incidence of arterial and venous thrombosis events. This is a retrospective cohort study using records
Yu-Han Chen +8 more
doaj +2 more sources